COVID-19 antibody testing and mental health assessment among healthcare workers
Official title: SARS-CoV-2 Seroprevalence Among Healthcare Workers: ARMOR Study Demonstration Project
Run by Columbia University · NCT04367857 · Data updated 2026-11-12
This study is testing how many healthcare workers at NewYork-Presbyterian Hospital have COVID-19 antibodies and how knowing their antibody status affects their mental health and coping during the pandemic.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 1000 (estimated) |
| Sponsor | Columbia University Academic / other |
| Locations | 1 site (New York, New York) |
| Status | Recruiting |
| Started | April 18, 2020 |
| Main results expected | February 2027 |
| Study ends | February 2027 |
| Registry record updated | April 8, 2026 |
| Trial ID | NCT04367857 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are healthcare personnel aged 18 and older who are employees or affiliates of NewYork-Presbyterian.
✕Probably not a fit
Patients who are younger than 18 years or those who are mentally or physically unable to complete study requirements may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to assess the prevalence of COVID-19 antibodies among healthcare workers at NewYork-Presbyterian Hospital. It will utilize both quantitative and qualitative serological assays to measure seroprevalence and evaluate the mental and emotional well-being of these workers. The study will also explore how knowledge of their serostatus impacts their coping strategies and overall psychosocial health during the pandemic. The findings are intended to improve testing protocols and support systems for healthcare workers facing COVID-19 challenges.
Why it matters
Potential benefit: If successful, this study could enhance the mental health support and testing strategies for healthcare workers during the COVID-19 pandemic.
How similar studies have gone: Other studies have shown success in assessing seroprevalence and mental health impacts among healthcare workers during the pandemic, indicating that this approach is both relevant and necessary.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18 years of age or older * NewYork-Presbyterian (NYP) healthcare personnel employee or affiliate * Understands and reads English Exclusion Criteria: * Younger than 18 years of age * Mentally and/or physically unable to complete study requirements
Where it's running
-
NewYork-Presbyterian Hosptial/Columbia University Irving Medical Center
New York, New York, United States Recruiting
Study contacts
- Principal investigator: Magdalena Sobieszczyk, MD, MPH — Columbia University
- Study coordinator: Brett Gray
- Email: bg2168@cumc.columbia.edu
- Phone: 212-305-1570
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Comparative Immunogenicity of Respiratory Virus Vaccines (CIRV2) in Adults
This study tests and compares the immune responses and tolerability of the latest COVID-19 vaccines from Novavax and Pfizer/BioNTech in adults at risk for severe COVID-19.
-
Testing a new method to detect COVID-19 using exhaled air
This study is testing a new breath test for COVID-19 to see if it works as well as the traditional nose swab method, especially for people showing symptoms or who have been around someone infected.
-
Aerosol box use during cardiopulmonary arrest
This project tests whether using an aerosol box during emergency airway procedures and chest compressions lowers particle spread and is practical for healthcare teams treating cardiac arrest patients, including those with COVID-19.
-
Omicron-based COVID-19 vaccine with Matrix-M given as a single dose in older adults and high-risk individuals
A single-dose Omicron-subvariant vaccine with Matrix-M is tested to see if it is safe and can induce an immune response in adults 65+ and in younger adults with conditions that raise the risk of severe COVID-19, who were previously vaccinated.
-
Secutrelvir for nonhospitalized COVID-19 in teens and adults
This study tests whether secutrelvir can help nonhospitalized people with COVID-19 see faster symptom relief compared with a placebo.
-
Virological Monitoring of Seasonal Respiratory Infections in France
This project tests how often common respiratory viruses show up in patients seen by primary care doctors in metropolitan France during the fall and winter.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.